Abvc Biopharma (ABVC) Exchange Rate Effect (2018 - 2026)
Abvc Biopharma's (ABVC) quarterly Exchange Rate Effect came in at $2640.0 in Q1 2026, down 61.35% YoY from $6830.0 in Q1 2025, and down 78.44% on a QoQ basis from $12246.0 in Q4 2025.
Abvc Biopharma (ABVC) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Abvc Biopharma (ABVC) has 9 years of Exchange Rate Effect data on file, last reported at $2640.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 61.35% year-over-year to $2640.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16074.0 (up 92.5% YoY) and the FY2025 annual result came in at $20264.0, up 182.41% from the prior year.
- Exchange Rate Effect eased to $2640.0 in Q1 2026, from $12246.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $322300.0 in Q2 2023 to a low of -$308804.0 in Q1 2023.
- A 5-year average of -$3935.1 and a median of $2640.0 in 2026 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 9162.27% — and 2025, when it surged 1421.41%.
- Tracing ABVC's Exchange Rate Effect over 5 years: stood at $219438.0 in 2022, then tumbled by 175.78% to -$166288.0 in 2023, then surged by 102.08% to $3465.0 in 2024, then soared by 253.42% to $12246.0 in 2025, then tumbled by 78.44% to $2640.0 in 2026.
- The last three Exchange Rate Effect figures came in at $2640.0 (Q1 2026), $12246.0 (Q4 2025), and $51804.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Abvc Biopharma | 23.34 Mn | 23.34 Mn | - | 11,355.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11,355.00 |
| Jun 30, 2026 | 11,355.00 |
| Mar 31, 2026 | 2,640.00 |
| Mar 31, 2026 | 2,640.00 |
| Dec 31, 2025 | 12,246.00 |
| Dec 31, 2025 | 12,246.00 |
| Sep 30, 2025 | 51,804.00 |
| Sep 30, 2025 | 51,804.00 |
| Jun 30, 2025 | -50,616.00 |
| Jun 30, 2025 | -50,616.00 |
| Mar 31, 2025 | 6,830.00 |
| Mar 31, 2025 | 6,830.00 |
| Dec 31, 2024 | 3,465.00 |
| Dec 31, 2024 | 3,465.00 |
| Sep 30, 2024 | 3,405.00 |
| Sep 30, 2024 | 3,405.00 |
| Jun 30, 2024 | -5,350.00 |
| Jun 30, 2024 | -5,350.00 |
| Mar 31, 2024 | -26,109.00 |
| Mar 31, 2024 | -26,109.00 |